Bestatin selectively suppresses the growth of leukemic stem/progenitor cells with BCR/ABL mRNA transcript in patients with chronic myelogeneous leukemia

International Immunopharmacology
Tomoaki FujisakiF Abe

Abstract

The in vitro effect of bestatin on Philadelphia (Ph) chromosome positive chronic myeloid leukemia (CML) was investigated using mature clonogenic cells and primitive stem cells derived from long-term culture-initiating cells (LTC-ICs). Individual colonies were grown in methycellulose culture (clonogenic cells) and after 5 weeks, LTC (colonies derived from LTC-ICs) were individually isolated. DNA isolated from these clonogenic colonies was studied by reverse transcriptase-polymerase chain reaction (RT-PCR) analysis to detect BCR/ABL mRNA transcripts b3a2 and b2a2. At the mature hematopoietic progenitor cell level, almost all (20/21) colonies, including both erythroid and myeloid progenitors, were leukemic, i.e. BCR/ABL mRNA positive. Although normal progenitors were able to grow in the presence of bestatin, even at the most primitive progenitor cell level (LTC-ICs), the number of leukemic clones gradually decreased. Furthermore, bestatin suppressed the outgrowth of leukemic clones more frequently than control LTC without any effect on the growth of normal clones. These results indicate that bestatin, at levels that can be obtained by per os administration clinically, suppresses only Ph-positive leukemic clones without affecting n...Continue Reading

References

Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C UdomsakdiA C Eaves
Jan 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·Y Lapidot-LifsonH Soreq
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·E S KawasakiF P McCormick
Jan 1, 1986·Cancer Immunology, Immunotherapy : CII·K OtaN Ogawa
Jan 1, 1995·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·T FujisakiY Niho
Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·K SekineK Nishikawa
Jul 4, 2002·Journal of the National Cancer Institute·Yuji MishimaKiyohiko Hatake

❮ Previous
Next ❯

Citations

Jun 17, 2006·The Journal of Investigative Dermatology·Anja ThielitzHarald Gollnick
Jul 23, 2004·Anti-cancer Drugs·Heiwa KanamoriYoshiaki Ishigatsubo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.